Form 4 for DMAC DiaMedica Therapeutics Inc.

Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-16 · accession 0001235802-21-000100 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-08-17	2021-08-16	DMAC	Pilnik Richard D.	Dir	P - Purchase	$3.27	+15.0K	83.1K	+22%	+$49.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Voting Common Shares, no par value per share	2021-08-16	P	A	12,500	$3.28	95,565	D	—	—	(F1) Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 19,887 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.
2	Common	Voting Common Shares, no par value per share	2021-08-16	P	A	2,500	$3.21	83,065	D	—	—	(F1) Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 19,887 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.